Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models
Patient-derived xenografts (PDXs) are important in vivo models for the development of precision medicine. However, challenges exist regarding genetic alterations and relapse after primary treatment. Thus, PDX models are required as a new approach for preclinical and clinical studies. We established...
Main Authors: | Ha-Yeon Shin, Eun-ju Lee, Wookyeom Yang, Hyo Sun Kim, Dawn Chung, Hanbyoul Cho, Jae-Hoon Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/3/829 |
Similar Items
-
Development of New Therapeutic Strategies in Gynecological Cancers in Iran by Utilizing Xenograft Model of Ovarian Adenocarcinoma
by: Zohreh Mazaheri, et al.
Published: (2010-09-01) -
Patient-Derived Xenograft Models in Cervical Cancer: A Systematic Review
by: Tomohito Tanaka, et al.
Published: (2021-08-01) -
Prognostic value of β-Arrestins in combination with glucocorticoid receptor in epithelial ovarian cancer
by: Ji-Won Ryu, et al.
Published: (2023-03-01) -
Sirtuins—The New Important Players in Women’s Gynecological Health
by: Ewa Maria Kratz, et al.
Published: (2021-01-01) -
Prognostic Role of the C-Reactive Protein/Albumin Ratio in Patients With Gynecological Cancers: A Meta-Analysis
by: Yingji Fang, et al.
Published: (2021-10-01)